Psychemedics Capital Expenditures vs End Period Cash Flow Analysis

PMD Stock

USD 2.72 0.01 0.37%

Psychemedics financial indicator trend analysis is much more than just breaking down Psychemedics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Psychemedics is a good investment. Please check the relationship between Psychemedics Capital Expenditures and its End Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.

Capital Expenditures vs End Period Cash Flow

Capital Expenditures vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Psychemedics Capital Expenditures account and End Period Cash Flow. At this time, the significance of the direction appears to have no relationship.

The correlation between Psychemedics' Capital Expenditures and End Period Cash Flow is 0.09. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Psychemedics, assuming nothing else is changed. The correlation between historical values of Psychemedics' Capital Expenditures and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Psychemedics are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Capital Expenditures i.e., Psychemedics' Capital Expenditures and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.09

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by Psychemedics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Psychemedics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

End Period Cash Flow

Most indicators from Psychemedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Psychemedics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.The current year's Enterprise Value is expected to grow to about 44.4 M, whereas Selling General Administrative is forecasted to decline to about 6.2 M.

	2021	2022	2023	2024 (projected)
Interest Expense	49K	43K	49.5K	47.0K
Depreciation And Amortization	3.7M	3.3M	2.7M	2.8M

Interest Expense Depreciation And Amortization

Psychemedics fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Non Currrent Assets Other	Other Current Assets	Short Long Term Debt Total	Other Current Liab	Inventory	Short Term Debt	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Other Assets
Total Assets		0.72	0.91	0.92	0.17	0.24	0.6	0.93	0.64	0.66	0.72	0.72	0.57	0.85	0.83	0.04	0.61	0.39	0.65	-0.05	0.14	0.32	0.15	-0.68	-0.69	0.2
Total Current Liabilities	0.72		0.56	0.65	0.22	-0.19	0.39	0.69	0.39	0.5	0.72	0.4	0.52	0.74	0.58	0.34	0.74	0.15	0.59	-0.34	0.59	0.28	0.31	-0.63	-0.63	0.12
Total Stockholder Equity	0.91	0.56		0.71	-0.19	0.38	0.74	0.71	0.82	0.61	0.69	0.42	0.53	0.55	0.95	0.05	0.59	0.25	0.8	-0.14	-0.13	0.26	0.04	-0.68	-0.68	0.03
Property Plant And Equipment Net	0.92	0.65	0.71		0.45	0.25	0.35	1.0	0.38	0.53	0.52	0.89	0.4	0.95	0.55	0.07	0.46	0.37	0.44	0.07	0.17	0.3	0.19	-0.47	-0.47	0.31
Net Debt	0.17	0.22	-0.19	0.45		-0.34	-0.55	0.45	-0.55	0.18	0.03	0.67	-0.01	0.59	-0.29	0.11	0.05	0.28	-0.42	0.13	0.51	0.14	0.36	0.02	0.02	0.57
Retained Earnings	0.24	-0.19	0.38	0.25	-0.34		0.34	0.22	0.53	-0.07	-0.35	0.12	-0.35	0.01	0.21	-0.06	-0.27	-0.07	0.39	0.11	-0.69	-0.08	-0.66	0.32	0.32	-0.14
Cash	0.6	0.39	0.74	0.35	-0.55	0.34		0.36	0.88	0.2	0.47	0.12	0.35	0.26	0.78	0.01	0.5	0.18	0.75	-0.24	-0.15	-0.07	-0.07	-0.46	-0.46	-0.13
Non Current Assets Total	0.93	0.69	0.71	1.0	0.45	0.22	0.36		0.39	0.54	0.54	0.88	0.41	0.95	0.56	0.09	0.48	0.36	0.45	0.05	0.2	0.29	0.19	-0.49	-0.49	0.31
Cash And Short Term Investments	0.64	0.39	0.82	0.38	-0.55	0.53	0.88	0.39		0.22	0.43	0.08	0.27	0.24	0.82	0.06	0.38	0.02	0.82	-0.25	-0.32	-0.05	-0.19	-0.42	-0.42	-0.13
Net Receivables	0.66	0.5	0.61	0.53	0.18	-0.07	0.2	0.54	0.22		0.77	0.45	0.77	0.55	0.67	-0.26	0.36	0.62	0.24	0.09	0.4	0.62	-0.01	-0.8	-0.8	0.23
Common Stock Shares Outstanding	0.72	0.72	0.69	0.52	0.03	-0.35	0.47	0.54	0.43	0.77		0.34	0.89	0.57	0.79	-0.08	0.69	0.44	0.46	-0.1	0.47	0.39	0.4	-0.99	-0.99	0.14
Non Current Liabilities Total	0.72	0.4	0.42	0.89	0.67	0.12	0.12	0.88	0.08	0.45	0.34		0.32	0.91	0.28	-0.17	0.21	0.53	0.05	0.29	0.24	0.25	0.17	-0.32	-0.32	0.44
Other Stockholder Equity	0.57	0.52	0.53	0.4	-0.01	-0.35	0.35	0.41	0.27	0.77	0.89	0.32		0.47	0.65	-0.34	0.49	0.49	0.23	0.03	0.4	0.65	0.26	-0.92	-0.92	0.01
Total Liab	0.85	0.74	0.55	0.95	0.59	0.01	0.26	0.95	0.24	0.55	0.57	0.91	0.47		0.46	0.02	0.47	0.46	0.3	0.07	0.44	0.31	0.25	-0.51	-0.51	0.37
Total Current Assets	0.83	0.58	0.95	0.55	-0.29	0.21	0.78	0.56	0.82	0.67	0.79	0.28	0.65	0.46		-0.04	0.64	0.32	0.77	-0.19	0.0	0.28	0.05	-0.79	-0.8	-0.01
Non Currrent Assets Other	0.04	0.34	0.05	0.07	0.11	-0.06	0.01	0.09	0.06	-0.26	-0.08	-0.17	-0.34	0.02	-0.04		0.35	-0.51	0.21	-0.82	0.1	-0.16	0.33	0.2	0.21	0.26
Other Current Assets	0.61	0.74	0.59	0.46	0.05	-0.27	0.5	0.48	0.38	0.36	0.69	0.21	0.49	0.47	0.64	0.35		0.15	0.63	-0.44	0.38	0.22	0.5	-0.62	-0.63	-0.03
Short Long Term Debt Total	0.39	0.15	0.25	0.37	0.28	-0.07	0.18	0.36	0.02	0.62	0.44	0.53	0.49	0.46	0.32	-0.51	0.15		-0.01	0.34	0.47	0.17	-0.16	-0.51	-0.51	0.49
Other Current Liab	0.65	0.59	0.8	0.44	-0.42	0.39	0.75	0.45	0.82	0.24	0.46	0.05	0.23	0.3	0.77	0.21	0.63	-0.01		-0.23	-0.14	-0.04	-0.05	-0.43	-0.43	-0.25
Inventory	-0.05	-0.34	-0.14	0.07	0.13	0.11	-0.24	0.05	-0.25	0.09	-0.1	0.29	0.03	0.07	-0.19	-0.82	-0.44	0.34	-0.23		-0.15	-0.05	-0.23	0.01	0.01	-0.24
Short Term Debt	0.14	0.59	-0.13	0.17	0.51	-0.69	-0.15	0.2	-0.32	0.4	0.47	0.24	0.4	0.44	0.0	0.1	0.38	0.47	-0.14	-0.15		0.15	0.29	-0.44	-0.43	0.43
Accounts Payable	0.32	0.28	0.26	0.3	0.14	-0.08	-0.07	0.29	-0.05	0.62	0.39	0.25	0.65	0.31	0.28	-0.16	0.22	0.17	-0.04	-0.05	0.15		0.11	-0.42	-0.42	-0.13
Property Plant And Equipment Gross	0.15	0.31	0.04	0.19	0.36	-0.66	-0.07	0.19	-0.19	-0.01	0.4	0.17	0.26	0.25	0.05	0.33	0.5	-0.16	-0.05	-0.23	0.29	0.11		-0.33	-0.33	0.14
Common Stock Total Equity	-0.68	-0.63	-0.68	-0.47	0.02	0.32	-0.46	-0.49	-0.42	-0.8	-0.99	-0.32	-0.92	-0.51	-0.79	0.2	-0.62	-0.51	-0.43	0.01	-0.44	-0.42	-0.33		1.0	-0.1
Common Stock	-0.69	-0.63	-0.68	-0.47	0.02	0.32	-0.46	-0.49	-0.42	-0.8	-0.99	-0.32	-0.92	-0.51	-0.8	0.21	-0.63	-0.51	-0.43	0.01	-0.43	-0.42	-0.33	1.0		-0.1
Other Assets	0.2	0.12	0.03	0.31	0.57	-0.14	-0.13	0.31	-0.13	0.23	0.14	0.44	0.01	0.37	-0.01	0.26	-0.03	0.49	-0.25	-0.24	0.43	-0.13	0.14	-0.1	-0.1

Click cells to compare fundamentals

Psychemedics Account Relationship Matchups

Psychemedics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.5M	24.0M	21.6M	18.7M	12.3M	15.1M
Total Current Liabilities	5.8M	3.9M	5.8M	5.7M	4.7M	2.7M
Total Stockholder Equity	16.8M	12.5M	12.2M	10.8M	6.7M	10.9M
Property Plant And Equipment Net	13.7M	13.5M	10.2M	7.3M	4.9M	4.8M
Net Debt	(1.3M)	6.1M	3.1M	(1.2M)	334K	350.7K
Retained Earnings	(3.8M)	(8.6M)	(9.6M)	(11.8M)	(16.8M)	(15.9M)
Cash	7.3M	2.8M	2.0M	4.8M	2.0M	3.4M
Non Current Assets Total	14.7M	14.4M	11.3M	8.8M	5.5M	5.4M
Cash And Short Term Investments	7.3M	2.8M	2.0M	4.8M	2.0M	1.9M
Net Receivables	3.8M	5.9M	6.8M	4.1M	3.7M	3.6M
Common Stock Shares Outstanding	5.5M	5.5M	5.5M	5.6M	5.7M	5.4M
Liabilities And Stockholders Equity	27.5M	24.0M	21.6M	18.7M	12.3M	15.1M
Non Current Liabilities Total	4.9M	7.6M	3.5M	2.2M	945K	1.8M
Other Stockholder Equity	22.2M	22.7M	23.4M	24.2M	25.0M	23.3M
Total Liab	10.7M	11.5M	9.3M	8.0M	5.7M	4.2M
Total Current Assets	12.9M	9.6M	10.3M	10.0M	6.8M	9.7M
Non Currrent Assets Other	(901K)	(1.7M)	864K	823K	632K	663.6K
Other Current Assets	1.8M	914K	1.5M	1.1M	1.0M	1.6M
Short Long Term Debt Total	6.0M	8.9M	5.1M	3.6M	2.3M	3.3M
Other Current Liab	3.6M	922K	2.0M	2.1M	1.0M	1.5M
Short Term Debt	1.6M	2.4M	2.6M	2.4M	2.4M	1.4M
Accounts Payable	617K	577K	994K	448K	752K	601.5K
Property Plant And Equipment Gross	13.7M	13.5M	10.2M	7.3M	28.5M	29.9M
Accumulated Other Comprehensive Income	(238K)	(1.4M)	(1.6M)	(1.6M)	(1.9M)	(2.0M)
Other Assets	943K	14.4M	1.0M	1.5M	1.7M	1.2M
Property Plant Equipment	10.9M	13.5M	10.2M	7.3M	8.3M	6.2M
Net Tangible Assets	16.8M	12.5M	12.2M	10.8M	12.4M	15.1M
Long Term Debt	2.0M	3.4M	599K	305K	350.8K	333.2K
Retained Earnings Total Equity	(2.1M)	(1.3M)	(3.8M)	(8.6M)	(9.9M)	(10.4M)
Capital Surpluse	31.0M	31.5M	32.2M	32.8M	37.7M	33.3M
Deferred Long Term Liab	737K	740K	700K	600K	540K	877.6K
Other Liab	1.2M	955K	550K	211K	189.9K	180.4K
Long Term Debt Total	2.4M	1.2M	2.0M	3.4M	3.1M	2.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports:

How To Invest In Psychemedics

Details

Is Psychemedics Stock a good investment?

Details

What is Psychemedics' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

(0.50)

Revenue Per Share

3.586

Quarterly Revenue Growth

(0.15)

Return On Assets

(0.16)

The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Psychemedics Capital Expenditures vs End Period Cash Flow Analysis

Capital Expenditures vs End Period Cash Flow

Capital Expenditures vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Capital Expenditures

End Period Cash Flow

Psychemedics fundamental ratios Correlations

Psychemedics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Psychemedics fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.95	Total Stockholder Equity
Total Liab	+ 0.95	Property Plant And Equipment Net
Total Liab	+ 0.95	Non Current Assets Total
Non Current Assets Total	+ 0.93	Total Assets

Common Stock	- 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.99	Common Stock Shares Outstanding
Common Stock	- 0.92	Other Stockholder Equity
Common Stock Total Equity	- 0.92	Other Stockholder Equity
Inventory	- 0.82	Non Currrent Assets Other
Common Stock	- 0.8	Total Current Assets